Current Rheumatology Reports
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 4.9 | Q1 | 82.8% | 1.506 | Q1 | 92.0% |
| 2024 | 3.9 | Q1 | 77.6% | 1.809 | Q1 | 94.4% |
| 2023 | 5.7 | Q1 | 91.2% | 1.551 | Q1 | 93.0% |
| 2022 | 5.0 | Q2 | 83.6% | 1.319 | Q1 | 91.4% |
| 2021 | 4.7 | Q2 | 69.2% | 1.200 | Q1 | 89.9% |
| 2020 | — | — | 1.393 | Q1 | 91.3% | |
| 2019 | — | — | 1.375 | Q1 | 91.4% | |
| 2018 | — | — | 1.287 | Q1 | 89.3% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1523-3774
ISSN
1534-6307
country
UScoverage
1999-2026